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Summary Statement 
This report investigates the autophagy dynamics of microglial cells stimulated with the 
neuropathogenic protein alpha-synuclein (AS) and its association with lysosomal damage 



























Autophagic dysfunction and protein aggregation have been linked to several 
neurodegenerative disorders, but the exact mechanisms and causal connections are not 
clear and most work was done in neurons and not in microglial cells. Here we report that 
exogenous fibrillar but not monomeric alpha-synuclein (AS) induces autophagy in 
microglial cells. We extensively studied the dynamics of this response by both live-cell 
imaging and correlative light-electron microscopy (CLEM) and found that it correlates with 
lysosomal damage and is characterised by the recruitment of the selective autophagy-
associated proteins TANK-binding kinase 1 (TBK1) and Optineurin (OPTN) to 
ubiquitinated lysosomes. In addition, we observed that LC3 recruitment to damaged 
lysosomes was dependent on TBK1 activity. In these fibrillar AS-treated cells, autophagy 
inhibition impairs mitochondrial function and leads to microglial cell death. Our results 
suggest that microglial autophagy is induced in response to lysosomal damage caused by 
persistent accumulation of AS fibrils. Importantly, triggering of the autophagic response 




























Neurodegenerative diseases are characterised by common cellular and molecular 
mechanisms including protein aggregation and inclusion body formation that result in 
toxicity and neuronal cell death (Lumkwana et al., 2017) .  
Autophagy dysfunction in the central nervous system (CNS) has been shown to induce 
neurodegeneration even in the absence of any disease-associated mutant proteins. Mice 
deficient for Atg5 (autophagy-related 5) develop progressive deficits in motor function that 
are accompanied by the accumulation of cytoplasmic inclusion bodies in neurons (Hara et 
al., 2006). On the other hand, mice lacking Atg7 specifically in the CNS showed 
behavioural defects, a reduction in coordinated movement and massive neuronal loss in 
the cerebral and cerebellar cortices (Komatsu et al., 2006). 
Although latest developments reveal a crucial role for the autophagy pathway in 
neurodegenerative diseases (Frake et al., 2015), the precise mechanisms underlying 
these processes are poorly understood. Furthermore, most of the existing literature related 
to autophagy in the CNS focuses on neurons and the effects of the autophagy pathway 
and its modulation on microglial cells remain slightly characterized. Microglia are resident 
macrophage cells in the CNS and have multiple functions, such as phagocytosis, 
production of growth factors and cytokines, and antigen presentation. The major function 
of microglia is to maintain homeostasis and normal function of the CNS, both during 
development and in response to CNS injury (Ransohoff, 2016). 
Canonical autophagy starts with the assembly of a pre-initiation complex consisting of 
ULK1, FIP200, and ATG13, which in turn leads to activation of the VPS34/Beclin-1 PI3K 
complex and then formation and extension of a double-membraned autophagosome 
around cellular contents by the lipidation of the autophagic protein light chain 3 (LC3), 
through the action of two ubiquitin-like conjugation systems. ULK1 is subject to regulatory 
phosphorylation by mTOR and AMPK, and this provides a means for the control of 
autophagy in response to nutrient status (Ktistakis and Tooze, 2016). 
Lipidated LC3 was once thought to unambiguously distinguish autophagosomes from 
other cellular membranes. However, these past recent years, a non-canonical autophagy 
mechanism was reported in the literature depending on direct LC3 association with single 
limiting-membrane vacuoles and able to deliver the luminal content towards lysosomal 
degradation (Martinez et al., 2011). This unconventional pathway is known as LC3-
associated phagocytosis (LAP) and it is involved in the maturation of single-membrane 























following recognition of pathogens by pattern recognition receptors and leads to the 
recruitment of LC3 into the phagosomal membrane (Martinez et al., 2015). 
Numerous autophagic receptors were reported to control the delivery of specific cargoes to 
the lysosomes through autophagy. Wild et al. characterized an autophagic adaptor, 
optineurin (OPTN), as a key component of pathogen-induced autophagy (Wild et al., 
2011). They also showed that this process was regulated by the activation of TANK-
binding kinase 1 (TBK1), which binds and phosphorylates OPTN on Ser177, leading to 
enhanced binding to Atg8 proteins, like LC3 (Wild et al., 2011). Recently, it has also been 
shown that the TBK1-OPTN axis targets damaged mitochondria for degradation via 
PINK1/parkin-mediated mitophagy (Moore and Holzbaur, 2016). As an upstream binding 
partner for the autophagy receptor, TBK1 phosphorylates OPTN on damaged 
mitochondria, leading to the formation of a TBK1-OPTN complex. Inhibition and depletion 
of TBK1 or OPTN blocks the efficient turnover of depolarized mitochondria. Interestingly, 
mutations of OPTN and TBK1 are both associated with neurodegenerative diseases 
including amyotrophic lateral sclerosis (ALS), Huntington's disease, Alzheimer's disease, 
Parkinson's disease, Creutzfeld-Jacob disease and Pick's disease (Korac et al., 2013; Li et 
al., 2016). However, the mechanistic basis underlying the specific interaction between 
OPTN and TBK1 in these disorders is still elusive.  
Parkinson's disease (PD) is a late-onset neurodegenerative disorder that mainly affects 
the motor system. Neuronal loss in the substantia nigra, which causes striatal dopamine 
deficiency, and Lewy bodies, intracellular inclusions containing aggregates of AS, are the 
neuropathological hallmarks of PD. AS may contribute to PD pathogenesis by distinct 
mechanisms, but novel evidences suggest that its aberrant fibril conformations are the 
toxic species that mediate disruption of cellular homeostasis and neuronal death, through 
effects on various intracellular targets, including synaptic function (Peelaerts et al., 2015). 
In addition, recent reports indicate that AS induce mitochondrial and lysosomal dysfunction 
and alters vesicular trafficking in PD, which may lead to AS accumulation (Di Maio et al., 
2016; Mazzulli et al., 2016). In this scenario, the autophagy pathway plays a critical role as 
the main mechanism responsible for abnormal protein and organelle degradation 
























Furthermore, secreted AS may exert deleterious effects on neighbouring neuronal and 
glial cells, including seeding of aggregation, thus contributing to disease propagation. A 
pivotal aspect of this cell-to-cell propagation is the ability of these aggregates to enter 
target cells and reach the cytosol where they induce further pathological protein 
aggregation.  
Even though several reports have indicated that neuronal-released amyloid aggregates 
can be internalized by glial cells (Asai et al., 2015; Kim et al., 2013; Loria et al., 2017), the 
mechanisms by which these toxic aggregates escape the endosomal compartment to 
access the cytosol and encounter the pool of naïve soluble proteins, promoting further 
protein aggregation, remains largely unknown. Understanding this mechanism of vesicular 
escape is essential to revealing the mechanisms underlying cell-to-cell propagation of 
amyloid pathology (Flavin et al., 2017). 
Recent research suggests a complex role for microglia not only in PD but in other 
disorders involving AS aggregation, such as multiple system atrophy (Sanchez-Guajardo 
et al., 2015). In addition, the novel concepts of AS being released in exosomes and 
uptaken by neighbouring cells, and their importance in disease progression, positions 
microglia as the main cell that can efficiently clear and handle AS (Chang et al., 2013; 
Longhena et al., 2017). 
Although significant progress has been done in unravelling the role and regulation of the 
autophagy machinery, its dysfunction in pathology as well as its dynamic changes in the 
disease progression remains largely unclear (Lumkwana et al., 2017). Further 
characterization of autophagy dynamics not only in neuronal but also in glial cells, in 
combination with analysis of the ultrastructural details of the several organelles and 
mechanisms involved in specific subtypes of autophagy, may contribute to the 
development of novel therapeutic approaches in PD and other neurodegenerative 
disorders. 
In this report we investigated for the first time the effect of monomeric and fibrillar AS on 
the autophagy activity of microglial cells. We observed that only fibrillar AS induces 
autophagy in microglial cells and that activation of the autophagy pathway is concomitant 
to lysosomal rupture. We provide the first evidences showing both the recruitment of TBK1 
and OPTN to ubiquitinated lysosomes, and the autophagy dynamics in association with 
high-resolution and live-CLEM in AS-stimulated microglial cells. Moreover, we found that 
LC3 recruitment to damaged lysosomes was dependent on TBK1 activity and autophagy 























cell death after fibrillar AS stimulation. Collectively, our results suggest that microglial 
autophagy is triggered as a rescue mechanism to restore lysosomal quality control and not 





Fibrillar but not monomeric AS induces autophagy in microglial cells 
We first analysed the effect of different AS aggregation states on autophagy induction in 
microglial cells. We stimulated BV2 and primary microglial cells with both exogenous 
fibrillar and monomeric AS at different time points. Based on a previous report from our 
group, we selected 1 M as protein concentration since no significant toxicity is observed 
either in BV2 or primary microglial cells after long-term cell culture (Bussi et al., 2017). 
Interestingly, we observed by immunofluorescence visualization (Fig. 1A) that only fibrillar, 
but not monomeric AS, increased the punctate localization of LC3. In addition, this 
response increased substantially after 12h of stimulation (Fig.1A). We did not find changes 
in the autophagic response after monomeric stimulation at all time-points studied.  
We next aimed to determine the subcellular localization of fibrillar AS after cellular 
internalization and its distribution in comparison to the autophagy marker LC3. We 
stimulated BV2 cells stably expressing GFP-LC3 (BV2 GFP-LC3) with Alexa Fluor 594 AS 
fibrils for 12h, then, BV2 cells were stained for lysosomal-associated membrane protein 1 
(LAMP-1). We found, by confocal microscopy and enhanced visualization by using 3D cell 
surface rendering approaches, that AS fibrils were confined to lysosomes and LC3 
vesicles were distributed around them (FIG. 1B-E). In addition, we obtained similar results 
by using primary microglial cells (FIG. 1F-I). In order to confirm lysosomal localization for 
AS fibrils, we analysed the co-localization between the lysosomal specific enzyme N-
acetylgalactosamine-6-sulfatase (GALNS) and fibrillar AS in primary microglial cells. 
Accordingly, these results showed high degree of co-localization between both labels (Fig. 
S1A). 
In parallel experiments, we studied the autophagic response by immunoblotting. Initiation 
of autophagy causes the conversion of LC3-I to LC3-II via the addition of a 
phosphatidylethanolamine (PE) group to the C terminus. We evaluated the conversion of 























terminally lipidated by PE, displaying higher electrophoretic mobility). In agreement with 
our previous results, we found an increase in the intensity of the LC3B-II band relative to 
the intensity of β-actin band after fibrillar but not monomeric AS stimulation (Fig. 1B and 
C). When Bafilomycin A1 (BAF) was added to fibrillar AS (hereafter fAS) stimulated cells, 
we observed an increase in the relative levels of LC3B-II in comparison with AS 
stimulation alone, indicating that fAS induces autophagy in microglial cells and it does not 
simply block autophagosome degradation (Fig. 1J). Overall, these results show that fAS 
has predominantly lysosomal localization after cellular internalization and it induces 
autophagy in microglial cells. The monomeric conformation was not able to activate the 
autophagy pathway at the time and dose studied.  
 
Autophagy dynamics of AS-stimulated microglial cells 
To further study the autophagic response triggered by fAS in microglial cells, we 
conducted live-imaging experiments at different time points after fAS stimulation. We used 
BV2 GFP-LC3 microglial cells and LysoTracker Blue for lysosomal staining. We did not 
observe a significant increase in LC3 puncta during the first 8h after fAS stimulation (Fig. 
S1B-D and Fig. S2A-C, Movie 1-4). Of note, fAS was quickly internalized during the first 20 
min by microglial cells and it showed lysosomal localization since the earliest time points 
(Fig. S1B-D, Movie 5). 
Interestingly, after 12h of stimulation we detected a substantial increase in the autophagy 
response. LC3 vesicles increased over time and were predominantly associated with 
LysoTracker +/ fAS + vesicles forming a ring-like structure around them, as observed 
previously by confocal analysis (Fig. 2A and B, Fig. S2C, Movie 6 and 7). In additional 
experiments, BV2 cells stably expressing GFP-ATG13 were co-transfected with CFP-LC3 
plasmid. ATG13 integrates the autophagy initiation complex ULK1, the most upstream 
complex of the autophagy pathway and it is essential for autophagosome formation (Axe 
et al., 2008; Karanasios and Ktistakis, 2015). In agreement with previous reports and 
autophagy dynamic studies (Ktistakis et al., 2014), we observed positive ATG13 signal as 
an early event during autophagosome formation, closely associated to LC3 puncta and its 
lifetime was shorter than the same structures containing LC3 (Fig. 2C and D, Fig. S2C, 
Movie 8 and 9). As seen before, the LC3 signal associated with ATG13 progressed into 
characteristic rounded structures around synuclein fibrils (Fig. 2C and D).  
Taken together these results indicate that the autophagic response to fAS follows a 























structures), but it is not an immediate event after synuclein treatment. The facts that 
lysosomes containing fAS are surrounded by LC3 vesicles suggests the possibility that the 
autophagic machinery may respond to lysosomal damage caused by the fibrils, and this is 
a question we will address later.  
 
 
CLEM study of fAS-stimulated microglial cells evidences canonical autophagy  
There are increasing reports showing the involvement of the non-canonical autophagy 
pathway in diverse pathological conditions since it was described for the first time. 
Although important advances have been made in the molecular characterization and 
differentiation between these alternative routes, we are still far from precisely 
understanding the mechanistic details and limits of both pathways (Dupont et al., 2017; 
Martinez et al., 2015). The principal difference between autophagosomes and non-
canonical vacuoles is that the former have two limiting membranes positive for LC3 
whereas the latter have one. In order to discriminate these different processes, we 
conducted CLEM experiments and analysed the presence of single or double membrane 
LC3-positive vesicles after fAS stimulation of BV2 GFP-LC3 microglial cells.  
We clearly detected double membrane autophagic vesicles (AV) mainly correlating with 
LC3-GFP signal and closely associated with fAS+ structures (Fig. 3A-F, Movie 10, 11 and 
12). Furthermore, we also observed double membrane vesicles and multi-membrane 
structures surrounded by a single-limiting membrane, probably as a result of fusion events 
between autophagosomes and lysosomes (Fig.3A-F, Movie 10, 11 and 12). These results 
are in agreement with a previous report describing similar AVs found on neocortical 
biopsies from AD human brain (Nixon et al., 2005). In agreement with Nixon et. al, the 
morphologies and composition of vesicles that accumulated after fAS treatment 
corresponded to those of the vesicular compartments of the autophagic pathway. Although 
we did not find enough evidence of quantitative ultrastructural analyses of glial organelles 
in the literature (Bisht et al., 2016), most of the vesicles we observed in fAS-stimulated 
microglial cells correlated with standard morphometric criteria for the immature and mature 
autophagosomes as expected for neural cells (Dunn, 1990a; Dunn, 1990b). These criteria 
include a size >0.5 um in diameter, a double-limiting membrane (immature), and the 
presence within a single vesicle of multiple membranous domains from organelle sources 
such as, Golgi, mitochondria or endoplasmic reticulum (Fig. 3C, D and E, Movie 10, 11 























single-membrane vesicles presented a smaller size in comparison to stimulated cells (Fig. 
S2D and E). Moreover, in order to improve the detection of autophagosomes around fAS+ 
vesicles, we carried out additional CLEM experiments with fAS-stimulated microglial cells 
previously treated with BAF. Similar to our previous results, we found examples where an 
autophagosome was in close proximity to a larger AV (Fig. 3I and J) and as expected, we 
also detected areas where double-membrane autophagosomes accumulated around other 
AVs (Fig. 3 G and H, Movie 13). 
To more precisely examine the ultrastructural nature of the AV formed after AS stimulation 
in microglial cells, we conducted live-CLEM assays. We stimulated BV2 GFP-LC3 cells 
with fAS for 12h and we followed the autophagy response by time-lapse widefield imaging 
and subsequent EM analysis (Fig. 4A and B). As we observed previously, an LC3 ring-like 
structure was formed around fAS (Fig. 4A). Interestingly, we found that the LC3-positive 
area predominantly correlated with a central double membrane autophagosome closely 
located to other single and double-membrane vesicles that were also positive for fAS 
signal (Fig. 4D and E, Movie 14 and 15). In an additional live-CLEM experiment (Fig. 4C, 
G and H, Movie 16 and 17) we observed that the region positive for LC3 signal correlated 
with concentrical multi-membrane structures with a central double membrane vesicle 
exhibiting a dense core. Moreover, these structures were in close contiguity with ER 
membranes, suggesting that the ER could be a main membrane donor in this process. 
These observations are in concordance with a previous electron tomography study 
showing that the ER associates with early autophagic structures and acts as a membrane 
source for autophagosome formation (Hayashi-Nishino et al., 2009).  
Overall, these results provide evidence of canonical autophagy, instead of LAP, as the 
main effector pathway in microglial cells after fAS internalization.  
 
Effects of fAS on lysosomal and mitochondrial quality of microglial cells.  
Galectin-3 (Gal-3) is a sugar binding protein which recognizes beta-galactoside normally 
only present on the exterior leaflet of the plasma membrane and the interior leaflet of 
intracellular vesicles (Sundblad et al., 2011). Gal-3 relocalization has been utilized to 
identify ruptured vesicles when bacteria and viruses enter the cytoplasm during infection 
(Maier et al., 2012; Thurston et al., 2012). Recent studies have also demonstrated that 
even in the absence of bacteria or viruses, some galectins can translocate to damaged 
lysosomes before their removal by the autophagic pathway (Freeman et al., 2013). Since 























lysosomal damage, we used a recently described protocol to assess lysosomal damage 
recognised by Gal-3 (Aits et al., 2015). We stimulated BV2 and primary microglial cells 
with labelled fAS at different time points and we analysed by confocal microscopy whether 
Gal-3 translocated to damaged lysosomes (Fig. 5). L-leucyl-L-leucine methyl ester 
(LLOMe), which induces lysosome-specific membrane damage (Uchimoto et al., 1999), 
was used as a positive control (Fig. 5A and B). In accordance with the autophagy 
dynamics previously described, we detected a significant change, from diffuse to punctate 
staining pattern, after 12h of fAS treatment but not during earlier time points or after 
monomeric AS stimulation (Fig. 5C, F and G). In addition, we observed a high extent of co-
localization of Gal-3 with both fAS and Lamp-1 (Fig. 5C and D). 
We next evaluated if the LC3 positive vesicles formed after fAS stimulation colocalized 
with Gal-3 puncta and found a high degree of co-localization. This suggests that lysosomal 
damage acts as a positive signal for autophagy activation in fAS-stimulated microglial cells 
(Fig. 5E). These results are in agreement with the manuscript by Flavin et al. (Flavin et al., 
2017) describing that lysosomes ruptured by AS in SH-SY5Y neuronal cells are targeted 
for autophagic degradation. We also assessed if fAS could disturb lysosomal activity by 
using a Cathepsin-B fluorometric assay to monitor enzyme activity at different time points 
after microglial cell stimulation. We found a significant increase in Cathepsin-B activity 
after 8h of treatment which diminished to basal levels after 12h (Fig. 5H), coincident with 
lysosomal impairment detection. These results indicate that lysosomes respond to the 
presence of fAS increasing Cathepsin-B activity which decreases with the progression of 
lysosomal damage. 
In parallel experiments, we also evaluated mitochondrial status since mitochondrial 
dysfunction has been associated with several neurodegenerative diseases and AS was 
shown to alter mitochondrial activity (Esteves et al., 2011). However, we did not find 
changes either in mitochondrial mass nor mitochondrial cell membrane potential after fAS 
stimulation at the different time points studied (Fig. 5I). Overall these findings indicate that 
fAS induces lysosomal but not mitochondrial damage, with a similar kinetic as observed to 


























TBK1 and OPTN are recruited to damaged lysosomes in AS-stimulated microglial 
cells 
Previous reports done in Salmonella enterica-infected HeLa cells have shown that TBK1 
directly phosphorylates the autophagic adaptor OPTN and this interaction allows the 
autophagic machinery to be recruited to the intracellular loci of the bacteria, resulting in 
elimination of the bacteria by lysosomes. On the other hand, OPTN has been observed in 
protein inclusions of various neurodegenerative diseases, such as ALS and PD. In 
consequence, we aimed to determine if TBK1 and OPTN could be recruited to damaged 
lysosomes in AS-stimulated microglial cells. 
Since the autophagy response was triggered at a similar time point to that described for 
AS-induced lysosomal damage (Fig. 5), we aimed to determine if microglial autophagy 
could be activated as an attempt to control lysosomal quality rather than by AS 
internalization itself. In consequence, we analyse by WB and confocal 
immunofluorescence the dynamics of TBK1 and OPTN activation in AS-stimulated 
microglial cells. 
Interestingly, we found that TBK1 and OPTN were significantly phosphorylated after 12h of 
fAS stimulation but not during earlier time points or after AS monomeric stimulation (Fig. 6A 
and B).  
In parallel experiments, we observed by confocal microscopy that TBK1 and OPTN co-
localize with ubiquitin and Gal-3 puncta in AS-stimulated BV2 and primary microglial cells 
(Fig. 6C and Fig. S3), indicating the recruitment of both proteins to ubiquitinated lysosomal 
damage sites. In accordance with our previous results (Fig. 6A and Fig. 5), TBK1 and OPTN 
puncta formation were only observed after 12h of fAS stimulation, which contrasted with the 
diffuse staining pattern observed in the control conditions (Fig. S3A and B). Moreover, we 
also observed LC3-positive/AS-positive vesicles co-localizing with both TBK1 and OPTN 
(Fig. 6D).  
In additional experiments, we analysed by confocal immunofluorescence if the autophagy 
receptors p62 and NDP52 would also be recruited to fAS-positive vesicles. Although mouse 
NDP52 is a truncated form lacking the C‐terminal zinc‐finger domain, which interacts with 
ubiquitin, it has been shown to bind phosphorylated tau via SKICH domain and to facilitates 
autophagy‐mediated degradation of tau in mouse (Jo et al., 2014; Minowa-Nozawa et al., 























Nonetheless, we did not observe co-localization of either NDP52 or p62 with fAS after 12h 
of stimulation (Fig. S4A and F). As expected, NDP52 did not co-localize with ubiquitin in 
fAS-stimulated microglial cells (Fig. S4C). Moreover, we did not find an increased in p62 
puncta formation after fAS stimulation in microglial cells (Fig. S4D and E), suggesting these 
adaptors do not collaborate in targeting fAS containing organelles.    
Taken together, these results show that TBK1 and OPTN activation and recruitment to 
damaged lysosomes displays a similar kinetic to that described for autophagy induction 
(Fig. 1 and Fig. 2), suggesting both proteins participate in the autophagic turnover of this 
organelle and that microglial autophagy is activated as a response to AS-induced 
lysosomal impairment. 
 
TBK1 inhibition impairs LC3 recruitment to damaged lysosomes 
In a previous report, Moore et al. (Moore and Holzbaur, 2016) showed that TBK1 and 
OPTN are recruited to mitochondria after acute damage and loss or chemical inhibition of 
TBK1 disrupts mitophagy. We next aimed to determine if TBK1 inhibition would affect 
autophagy adaptors recruitment and LC3 targeting of damaged lysosomes in fAS-
stimulated microglial cells. Firstly, we evaluated the ability of blocking TBK1 activity by 
using BX795, mrt67307 and Amlexanox, three different TBK1 chemical inhibitors. As 
shown in Fig. 7A, all treatments supressed TBK1 phosphorylation in fAS-stimulated 
microglial cells.  
In additional experiments, we analysed LC3 puncta formation and LC3-II induction in fAS-
stimulated BV2 GFP-LC3 microglial cells pre-treated with Amlexanox, which has been 
reported as one of the most specific inhibitors of TBK1 (Reilly et al., 2013; Yu et al., 2015). 
We observed marked decrease of both, LC3-positive vesicles and relative LC3-II protein 
levels in cells with impaired TBK1 activity (Fig.7B, C and E). Moreover, it correlated with a 
decrease in p-TBK1 and OPTN puncta formation after fAS stimulation in microglial cells 
(Fig. 7F, G, H and I). As expected, Gal-3 puncta formation was not affected by TBK1 
inhibition in fAS-stimulated microglial cells (Fig. 7J), suggesting lysosomal damage is a 
result of fAS accumulation and it occurs independently of TBK1 activity. 
On the other hand, TBK1 blockade did not modify LC3 puncta levels in microglial cells 
treated with the mTORC1 inhibitor PP242 (Fig. 7D and E), which indicates that only 
autophagy activated by lysosomal damage was affected by TBK1 inhibition. 
Overall, our results showed that OPTN and LC3 recruitment to damaged lysosomes in 
























Autophagy prevents cell death in fAS-stimulated microglial cells 
Autophagy is intimately associated with eukaryotic cell death and apoptosis. However the 
molecular connections between autophagy and cell death are complex and, in different 
contexts, autophagy may promote or inhibit cell death (Arroyo et al., 2013; Degenhardt et 
al., 2006; Green and Levine, 2014). We therefore evaluated the effects of autophagy 
inhibition on microglial cell survival. We inhibited autophagy by using spautin-1, which 
promotes the degradation of VPS34 PI3 kinase complexes by inhibiting two ubiquitin-
specific peptidases, USP10 and USP13 that target the Beclin1 subunit of VPS34 
complexes (Liu et al., 2011). In addition, we also used a siRNA targeting FIP200, a pivotal 
protein required for autophagy induction and autophagosome formation (Hara et al., 2008). 
We evaluated the ability of spautin-1 and siRNA FIP200 to inhibit autophagy by confocal 
microscopy analysis of LC3 puncta formation after treating BV2 GFP-LC3 microglial cells 
with PP242, a specific mTORC1 inhibitor and autophagy inducer. We observed that both 
treatments significantly suppressed the autophagy response (Fig. S5A and B). Moreover, 
autophagy blockade by spautin-1 and siRNA FIP200 also decreased LC3 puncta formation 
in fAS-stimulated primary microglial cells (Fig. S5C). 
We next investigated whether autophagy inhibition prior to fAS stimulation affects 
microglial cell viability. BV2 and primary microglial cells were cultured in the presence or 
the absence of spautin-1 or siRNA FIP200 and stimulated with fAS for 24h, then we 
evaluated microglial cell death by flow cytometry. We found an increase in the frequency 
of dead cells (AnV+/PI+) when autophagy was inhibited by these treatments in fAS-
stimulated microglial cells. Similar results were obtained with both BV2 and primary 
microglial cells (Fig. 8A and B). 
Mitochondrial outer membrane permeabilization (MOMP) is often required for activation of 
the caspase proteases that cause apoptotic cell death. As a consequence, mitochondrial 
outer membrane integrity is highly controlled, primarily through interactions between pro- 
and anti-apoptotic members of the B cell lymphoma 2 (BCL-2) protein family (Tait and 
Green, 2010). Bcl-2 and Bcl-xL anti-apoptotic proteins promote cell survival by preventing 
mitochondrial membrane permeabilization and subsequent content release which leads to 
caspase activation and ultimately, programmed cell death (Shamas-Din et al., 2013).  
On the other hand, lysosomal damage and resulting lysosomal membrane 
permeabilization have been shown to induce apoptosis through MOMP, which can be 























cleavage of anti-apoptotic Bcl-2 and Bcl-xL proteins (Aits and Jaattela, 2013; Cirman et al., 
2004; Droga-Mazovec et al., 2008). Here, we also evaluated by flow cytometry the 
expression levels of Bcl-2, Bcl-xL and cleaved caspase-3 in fAS-stimulated BV2 microglial 
cells in the presence or the absence of both autophagy inhibitors. We found a decreased 
in Bcl-2 and Bcl-xL protein levels with a concomitant increase in cleaved-caspase-3 
expression when autophagy was impaired (Fig. 8C). In parallel experiments we analysed 
mitochondrial mass and membrane potential changes after autophagy inhibition in fAS-
stimulated microglial cells. We detected an increase in mitochondrial mass, but a decrease 
in the mitochondrial membrane potential, after autophagy blockade (Fig. 8D and E). 
Moreover, autophagy inhibition also led to the accumulation of damaged lysosomes in 
fAS-stimulated microglial cells. This was evidenced by an increase in Gal-3 puncta at 
earlier time points after treatment and a diminished LysoTracker Red DND-99 staining 
(Fig. 8F, G and H). Overall, it indicates the autophagy requirement for mitochondrial and 
lysosomal homeostasis.  
Collectively, our results showed that AS induced lysosomal damage and autophagy 
activation and the inhibition of this degradative pathway led to mitochondrial and lysosomal 
quality impairment, which includes MOMP, and consequent microglial cell death. 
 
DISCUSSION 
Misfolding and intracellular aggregation of AS are thought to be crucial factors in the 
pathogenesis of Lewy body diseases (LBDs), such as PD. Recent studies suggest that 
small amounts of AS are released from neuronal cells by unconventional exocytosis, and 
that this extracellular AS contributes to the major pathological features of LBD, such as 
neurodegeneration, progressive spreading of AS pathology, and neuroinflammation (Lee 
et al., 2014). In these neurodegenerative processes, the activation of microglia is a 
common pathological finding, which disturbs the homeostasis of the neuronal environment. 
Microglia’s behaviour is therefore a determinant on the disease’s progression. 
In our present study, we show by confocal microscopy and immunoblotting analysis that 
fAS but not its monomeric conformation induces autophagy in microglial cells. Our results 
are in accordance with previous observations showing that AS fibrils are more potent 
cellular activators than other aggregation states. In agreement with a recent article from 
our group, Hoffman et al. found that fAS increased the production and secretion of pro-
inflammatory cytokines in microglial cells in a greater extent than oligomers or monomers 























Autophagy is a highly dynamic pathway and live-cell imaging has been extensively used to 
follow autophagy events in real-time (Karanasios and Ktistakis, 2015). Nonetheless, most 
of the studies monitoring the autophagic flux in glial cells were done by fluorescence 
microscopy of fixed cells and little is known about autophagy dynamics in microglial cells. 
Here, we extensively characterized the autophagy dynamics of microglial cells stimulated 
with fAS by live-cell imaging. We observed that although fAS is quickly internalized by 
microglial cells, autophagy induction was evident after 12h of stimulation (Fig. 1 and 2). 
Interestingly, we observed that LC3 decorated lysosomes containing fAS forming a ring-
like structure around them. In additional experiments with stably expressing ATG13 BV2 
cells, we detected ATG13-positive structures that progresses into LC3-positive vesicles, 
which coincides with previous autophagy dynamic reports (Karanasios and Ktistakis, 2015; 
Ktistakis et al., 2014) and suggest that the autophagic response to fAS follows a canonical 
pathway (Fig. 2C and 2D).  
The kinetics of autophagy we observed contrasts with dynamics studies of LAP where 
phagosomes are rapidly decorated with LC3, usually within minutes (Martinez et al., 2011). 
Although we cannot rule out the involvement of the non-canonical pathway during this 
process, we could effectively correlate by high-precision and live-CLEM approaches, LC3-
positive structures with double-membrane bound AV formed after fAS stimulation (Fig. 3 
and 4), indicating a predominant role for the canonical autophagy pathway rather than its 
alternative route during this process. 
Recent evidence indicates that AS could disturb neuronal metabolism, by inducing 
lysosomal and mitochondrial damage (Bourdenx et al., 2014; Freeman et al., 2013; Xilouri 
et al., 2016). Nevertheless, the effects of AS on glial organelles is poorly understood. Here 
we report that although fAS is rapidly incorporated into lysosomes after cellular 
internalization, it induces lysosomal damage and TBK1/OPTN recruitment at the same 
time point as when the autophagy response is significantly activated (Fig. 5, 6 and Fig. 
S3). Moreover, we showed a high degree of co-localization between LC3 and Gal-3 puncta 
and between LC3 and TBK1 and OPTN puncta, suggesting that lysosomal damage rather 
than fAS acts as an activator signal for autophagy induction. Importantly, we observed that 
TBK1 inhibition disrupts OPTN and LC3 recruitment to damaged lysosomes in fAS-
stimulated microglial cells, but it did not affect autophagy induced by mTORC1 blockade. 
Collectively, these results suggest that OPTN is recruited to lysosomes damaged by 























may allow subsequent recruitment of LC3 and the autophagy machinery as a cellular 
attempt for restoring lysosomal quality control. 
In this line of evidence, Flavin et al. (Flavin et al., 2017) observed by immunofluorescence 
microscopic analysis on sections from PD patients that LBs and other amyloid aggregates 
were surrounded by Gal-3, suggesting that endocytic vesicle rupture is a conserved 
damaging mechanism of cellular invasion by amyloid proteins. 
In agreement with our results, Freeman et al. (Freeman et al., 2013) showed that AS 
induces lysosomal rupture and Cathepsin-B release in neuronal cells after endocytosis. In 
addition, cysteine cathepsins were shown to be pivotal for lysosomal degradation of AS 
fibrils (McGlinchey and Lee, 2015). Although we observed a sharp increase in Cathepsin-B 
levels 8h after fAS stimulation, it notably diminished 12h after treatment which could 
indicate an overwhelmed lysosomal ability to degrade AS aggregates, leading ultimately to 
lysosomal damage (Fig. 7A). Collectively, considering these evidences and our data 
shown here, we propose that accumulation of pathological protein aggregates and the 
formation of inclusions such as LBs arise from the failure of cellular attempts to degrade 
ruptured vesicles (and their amyloid contents) through the autophagy-lysosome pathway. 
Although previous reports have indicated that AS induces mitochondrial damage in 
neurons (Bir et al., 2014; Martin et al., 2006), we did not find significant changes either in 
mitochondrial mass or membrane potential at the different time points studied, indicating 
that fAS does not alter mitochondrial quality during the first 48h of stimulation in microglial 
cells (Fig. 7B). 
There are increasing research articles providing evidence about the pivotal role of 
autophagy during CNS homeostasis and disease progression (Hara et al., 2006; Komatsu 
et al., 2006; Nikoletopoulou et al., 2015). However, the role of autophagy in glia and the 
contribution of defective glial autophagy in neurodegeneration remain poorly 
characterized. 
In this report, we analysed the effect of disrupting autophagy on microglial cell survival 
after fAS stimulation. We observed by both spautin-1 treatment and down-regulation of 
FIP200 by siRNA increased levels of cell death of fAS-stimulated microglial cells (Fig. 7C 
and 7D). Our findings agreed with a previous report indicating that neural-specific deletion 
of FIP200, involved in autophagosome biogenesis, caused axonal degeneration in 
cerebellar neurons eventually causing their death (Liang et al., 2010). 
The mitochondria-mediated caspase activation pathway is a major apoptotic pathway 























activate caspases. MOMP is regulated by the Bcl-2 family of proteins which act as 
inducers or blockers of the process (Xiong et al., 2014). Of relevance to this work, it has 
been shown that lysosomal damage can induce MOMP-dependent cell death and 
lysosomal proteases released into the cytosol have been implicated in apoptotic cell death 
(Repnik et al., 2014). In the present study, we found that autophagy inhibition increased 
mitochondrial mass but impaired mitochondrial membrane potential, down-regulated Bcl-2 
and Bcl-xL protein levels and increased cleaved caspase-3 protein expression in fAS-
stimulated BV2 cells, which suggest activation of apoptosis (Fig. 7E and 7F). Moreover, 
autophagy blockade led to the accumulation of ruptured lysosomes after fAS stimulation in 
microglial cells, which indicates the requirement of functional autophagic activity for 
removing damaged lysosomes. Although lysosomal damage may have an autophagy-
blocking effect after persistent stress conditions, experimental evidences, in agreement 
with our results, showed that lysosomes damaged by lysosomotropic reagents are 
selectively isolated by autophagy and disruption of this pathway caused inhibition of 
lysosomal biogenesis (Maejima et al., 2013).  
Although we cannot disregard additional upstream signals triggering MOMP, we consider it 
likely that lysosomal damage, together with the inability of the autophagic pathway to clear 
this organelle, leads to MOMP and ultimately to cell death. Collectively, our results suggest 
a protective role for the autophagy pathway in fAS-stimulated microglial cells.  
Extracellular AS has emerged as a crucial player in the pathogenesis of LBDs and other 
synucleinopathies, such as PD and multiple system atrophy (Lee et al., 2014). Recent 
studies have provided evidence that extracellular AS alone, particularly fibrils, can be 
responsible for all the major pathological changes in neurodegenerative diseases: 
aggregate deposition and spreading, neuroinflammation and neurodegeneration 
(Peelaerts et al., 2015). Although several articles have indicated that extracellular AS 
activates microglial cells (Bussi et al., 2017; Codolo et al., 2013; Hoffmann et al., 2016), 
this is to the best of our knowledge, the first study showing that fAS recruits TBK1 and 
OPTN to ubiquitinated lysosomes and induces autophagy in microglial cells. In addition, 
we also characterized the microglial autophagy dynamics by correlating light-microscopy 
imaging with the specific ultrastructural morphology of the autophagic compartments 
























These findings provide new insights into the effects of extracellular AS on microglial cells 
and propose autophagy as a rescue mechanism activated to restore lysosomal quality 
control after fAS-induced organelle rupture. We anticipate that further studies evaluating 
the molecular mechanisms triggered by protein aggregates and its crosstalk with the 
autophagy pathway not only in neurons, but also in glial cells would shed light on novel 
therapeutic targets for neurodegenerative disorders. 
 
 
MATERIALS AND METHODS 
 
Reagents 
Dulbecco’s Modified Eagle Medium (DMEM), Opti-MEM, fetal bovine serum (FBS), 
penicillin, glutamine, G418, streptomycin, Silencer select FIP200 siRNA (4390771), 
Silencer select negative control 1 (4390843), Lipofectamine RNAiMAX (13778100) and 
LysoTracker Blue (L7525) were obtained from Thermo Fischer Scientific (Grand Island, 
NY, USA). Antibodies used for western blotting were rabbit polyclonal anti-LC3 (Sigma, 
L7543), mouse monoclonal anti -actin (Cell Signaling, 8H10D10), rabbit polyclonal anti-
Optineurin (Cayman, 100000), mouse monoclonal anti-TBK1 (Santa Cruz, 398366) and 
rabbit monoclonal anti-phosphoTBK1 (Cell Signaling, 5483S). Antibodies used for 
immunofluorescence were rabbit monoclonal anti-LC3 A/B (Cell Signaling, D3U4C), rat 
monoclonal anti LAMP-1 (Biolegend, 121601), mouse monoclonal anti-Galectin-3 
(Biolegend, 125401), rabbit polyclonal anti-GALNS (GeneTex, 110237), rabbit polyclonal 
anti-Optineurin (Cayman, 100000), mouse monoclonal anti-TBK1 (Santa Cruz, 398366) 
and mouse monoclonal anti-Ubiquitin (Cell Signaling, 3936S). PP242 (13643) and BafA1 
(11038) were purchased from Cayman (Ann Arbor, MI, USA). Spautin-1 (SML0440) was 
purchased from Sigma. MRT-67307 (19916) and Amlexanox (14181) were purchased 
from Cayman. BX795 (HY-10514) was purchased from MedChemExpress (Princeton, NJ, 
USA). MitoSpy™ Green FM and MitoSpy™ Orange CMTMRos were obtained from 
Biolegend (San Diego, CA, USA). Magic Red™ Cathepsin-B Kit was purchased from Bio-
Rad (Hercules, CA, USA). FITC Annexin V Apoptosis Detection Kit was purchased from 

























Cell culture and transfections 
The murine microglial cell line BV2 was a kind gift from Dr. Dennis J. Selkoe (Harvard 
Medical School, Center for Neurological Diseases, Brigham and Women’s Hospital, 
Boston, MA, USA). The cells were grown in DMEM supplemented with 10% heat-
inactivated FCS, 2mM glutamine and 100 ug/ml streptomycin and maintained at 37°C and 
5% CO2. 
For stable GFP-LC3 expression, BV-2 cells were transduced with pBabe-GFP-LC3 
retrovirus generated as previously described (Florey et al., 2011). Cells were selected with 
10g/ml blasticidin for 4 days. BV2 stably transfected with ATG13 were cultured in media 
identical in composition to wild-type media, except for the addition of 400 μg/ml G418. BV2 
cells were transfected with X-tremeGENE™ HP DNA Transfection Reagent (Roche, 
06366236001) following manufacturer's indications. CFP-LC3 plasmid was a kind gift from 
Dr. Tamotsu Yoshimori. Silencer Select FIP200 (Thermo Fischer, 4390771) and negative 
control siRNAs (Thermo Fischer, 4390843) solutions were prepared according to the 
manufacturer's instructions and experiments were performed 48h after transfection. 
Lipofectamine RNAiMAX (Thermo Fischer, 13778100) was used as transfection reagent. 
 
Isolation of primary microglial cells from adult mice 
After perfusion with PBS, brains from 6- to 8-wk-old mice C57BL/6J, (15 mice/group) were 
collected in DMEM, dispersed with scissors, resuspended in PBS containing 0.3% 
collagenase D (Roche, Indianapolis, IN, USA) and 10 mM HEPES buffer (Invitrogen, 
Carlsbad, CA, USA), and incubated 30 min at 37°C. Brain homogenates were then filtered 
in 70-_m-pore cell strainers (Becton Dickinson), centrifuged (7 min, 1500 rpm), washed, 
and resuspended in 70% isotonic Percoll (GE Healthcare, Fairfield, CT, USA). Cell 
suspension (3.5 ml) was transferred to 15-ml polypropylene conical tubes with 5 ml of 25% 
isotonic Percoll, which were sequentially layered on top with 3 ml of PBS. After 
centrifugation (30 min, 800 g, 4°C), the 70%:25% Percoll interphase layers were collected, 
and the cells were washed. Finally, the adherent cells, which contained 90% of CD11b+ 
cells, were cultured in DMEM supplemented with 10% heat-inactivated FCS, 2 mM 
glutamine, 100 U/ml penicillin, 100 ug/ml streptomycin, 100 ug/ml sodium pyruvate, and 10 
mM HEPES buffer (Invitrogen). Microglial cells were washed with PBS and resuspended in 
medium containing 10% heat-inactivated FCS, alpha-synuclein, or other stimuli and then 























contrast phase microscope. Animal care was provided in accordance with the procedures 
outlined in the U.S. National Institutes of Health (NIH) Guide for the Care and Use of 
Laboratory Animals (Publication 86-23, 1985). The experimental protocols were approved 
by the Institutional Animal Care and Use Committee of Centro de Investigaciones en 
Bioquímica Clínica e Inmunología (CIBICI), Consejo Nacional de Investigaciones 
Científicas y Técnicas (CONICET). Our animal facility obtained NIH animal welfare 
assurance (assurance no. A5802-01, Office of Laboratory Animal Welfare, NIH, Bethesda, 
MD, USA). 
 
Cell culture treatments 
BV2 cells were grown in six well plates to 65 to 70% confluence (for immunofluorescence) 
or 70 to 80% confluence (for western blotting) before treatments. Primary microglial cells 
were grown in chamber slides or 48 well plates to 65 to 70% confluence before treatments. 
AS fibrils and monomers were used at 1M at indicated time points. PP242 was used at 
1M for 3h.  Mammalian PI3KC3 was blocked by the addition of spautin-1 (10 M) for 24h 
before stimulation. TBK1 was inhibited by the addition of BX795 (1 M), MRT-67307 (1 
M) or Amlexanox (1 M) for 1h before stimulation. Autophagosome maturation was 
blocked using BAF, at final concentration of 200 nM, in normal growth medium for 1 h, 
unless otherwise stated.  
 
Preparation of monomeric and aggregated AS 
Monomeric AS stock solutions were prepared in PBS buffer and 0.02% sodium azide and 
centrifuged (14100 g, 30 min) before use in order to remove possible aggregates. After 
that, solutions were sterilized by filtration (22 um pore size). Protein concentration was 
determined by absorbance using an ε275 of 5600 M−1 · cm−1. Fibrillation was achieved 
by incubating 400 μM monomeric AS stock solutions at 70°C and 800 rpm in a 
Thermomixer5436 (Eppendorf), conditions that lead to faster aggregation kinetics (Celej et 
al., 2012) Fibril formation was monitored using the ThioT (thioflavin T) fluorescence assay. 
Fibrils were isolated by three consecutive cycles of centrifugation (14000 g, 30 min) and 
resuspended in PBS buffer. Protein concentrations in monomeric units were determined 
by the absorbance of aliquots incubated in 6 M guanidinium chloride at 25◦C for 24 h. 
Endotoxin levels were evaluated by Limulus Amebocyte Lysate (LAL) assay. Endotoxin 
content was lower than detection limit (<0,24 EU/mL). AS protein labelling: AS fibrils were 























(Molecular Probes, A2004) NHS Ester dye according to manufacturer´s instructions. The 
label density of the fluorophore in the fibril preparation was 5% to ensure a negligible effect 
on the fibril structure. We carefully checked the ultrastructure (TEM) (Fig. S5D), tinctorial 
properties (ThioT) and secondary structure features (IR) of labeled fibrils and compare 




After treatment with AS fibrils or monomers, 2x106 BV2 microglial cells were harvested by 
centrifugation at indicated time points. After washing with PBS, cells were lysed using 
sample buffer. Subsequently, cells lysates were sonicated and boiled. Proteins were 
electrophoresed on 12% SDS-PAGE gel under reducing conditions and transferred on to 
Immun-Blot PVDF Membrane (Bio-Rad, Hercules, CA, USA). The membranes were 
blocked with 5% nonfat milk and 0.1% Tween-20 in TBS for 2h at room temperature and 
then were incubated with primary antibodies overnight at 4°C. Then, membranes were 
incubated with secondary antibodies (IRDye, LI-COR Biosciences, Lincoln, Nebraska, 
USA) for 1h and 30 min at RT and protein bands were detected with an Odyssey Infrared 
Imaging System (LI-COR Biosciences).  
 
Immunofluorescence assays: 
Following the appropriated treatments BV2 cells grown on glass coverslips in 6-well plates, 
or primary microglial cells grown on Lab-Tek chamber slides (Thermo Fischer), were fixed 
with 100% ice-cold metanol for 10 min on ice. The cells were then blocked for a minimum 
of 1 h in 5% (w/v) BSA)/PBS before staining with the appropriate primary antibodies. After 
3 rinses with PBS, samples were incubated with Alexa Fluor 488 or Alexa Fluor 546 
secondary antibodies (Invitrogen) for 60 min. The slides were analysed under a laser 
scanning confocal fluorescence microscope (Olympus FV1000; Olympus, Tokyo, Japan) 
or under a wide-field fluorescence microscope (Leica DMi8, Leica, Weitzlar, Germany). 
Galectin puncta assay: Staining for immunofluorescence and image analysis were done 
following a previously characterized protocol (Aits et al., 2015). Briefly, BV2 or primary 
microglial cells were incubated in the presence or the absence of fibrillar AS and 
immunolabeled with a monoclonal rat anti-mouse galectin 3 antibody (Biolegend, 125402).  
Alternatively, immunostaining with a monoclonal rat anti-mouse galectin-3 Alexa Fluor 488 























images were acquired under a wide-field or laser scanning confocal fluorescence 
microscope and galectin-3 puncta formation was followed over time. Incubation for 2h at 
37ºC with a 500 M solution of LLOME crystals was used as positive control of lysosomal 
damage. Spatial deconvolution, 3D surface-rendered images and 3D surface-rendered 
movies were carried out with SVI Huygens Software. Image processing and analysis were 
performed using FIJI (Fiji Is Just ImageJ) Open Source software (Schindelin, Arganda-
Carreras et al., 2012). Co-localization analyses were performed after z-stack 
deconvolution by using SVI Huygens Software. LC3, Gal-3, pTBK1, OPTN and Ubiquitin 
puncta quantification in BV2 cells was done after analysis of at least 4 different fields with 
15-20 cells each. For experiments with primary cells, at least 20 cells were analysed per 
condition. Statistical analyses show mean and SEM of 3 independent experiments. 
 
Live-cell imaging: 
Live-cell imaging was performed in cells that had been plated on to 22-mm diameter 
coverslips (BDH) and transiently transfected with the relevant constructs. Individual 
coverslips were placed in an imaging chamber with 2 ml of medium and the appropriate 
treatment. LysoTracker Blue (1:10000; Thermo Fischer, L7525), where stated, was added 
to samples 30 min before imaging began. Samples were then placed in a Solent 
environment chamber (Solent Scientific, custom made) before mounting on the 
microscope, all at 37°C. Widefield imaging experiments were performed on a Nikon Ti-E-
based system. The Nikon Ti-E-based system comprised a Nikon Ti-E microscope, 100x 
1.4 N.A. objective (Nikon), SpecraX LED illuminator (Lumencor), 410/504/582/669-Di01 
and Di01-R442/514/561 dichroic mirrors (Semrock), Hamamatsu Flash 4.0 sCMOS 
camera, emission filter wheel (Sutter Instruments) and was controlled using Nikon 
Elements software. Excitation and emission filters (all from Semrock) were as follows: CFP 
434/17 (ex) 480/17 (em), GFP 480/10 (ex) 525/30 (em), mRFP 560/25 (ex) 607/36 (em).  
Analysis of live-cell imaging videos: Live-cell imaging videos were analysed with Fiji as 
previously described (Karanasios and Ktistakis, 2015; Karanasios et al., 2016) In brief, the 
montages of independent events were created from the captured videos. We consider as 
an independent event all the frames that correspond to the formation and collapse of GFP-
LC3, GFP-ATG13 or RFP-LC3 particles (as stated in Fig. S2C), starting and finishing with 
the frames in which the fluorescence of the particle is clearly above the background 
fluorescence. Frames corresponding to time points before the beginning or after the end of 























out of focus and then back in were excluded from the analysis. For the analysis of the 
distance among GFP-LC3, RFP-LC3 or GFP-ATG13 and the different markers, the same 
coordinates were used to create montages of the other markers and composite images of 
the two channels were created to analyse the co-localization of the two proteins. Lines 
were drawn crossing the sites of closest association (judged by eye in large magnification) 
and line plots of the fluorescence intensity were used to decide on association. Association 
was scored when the same pixels had signal above the background for both channels and 
the mean of association scores (expressed as percentages) was calculated. At least 50 
montages were used for analysis. 
 
Correlative Light-Electron Microscopy (CLEM) experiments: 
Widefield-electron microscopy correlation assays: BV2 GFP-LC3 cells were cultured on 3-
mm carbon-coated sapphire discs and stimulated with labelled AS (3uM) for 12h. High 
pressure freezing, ultrathin sectioning for electron microscopy, image acquisition and 
correlation analysis were done as described previously (Kukulski et al., 2012). Briefly, after 
cellular stimulation, microglial cells were high pressure frozen using an Abra Fluid HPM-
010 (Abra Fluid, Switzerland) and transferred to the automated freeze substitution 
apparatus (Leica EM AFS2) under liquid nitrogen. Semithick 300-nm sections were 
prepared using a Leica UC6/UF6 ultramicrotome and picked up on finder 200 mesh 
copper grids coated with carbon. After that, immunofluorescence images were acquired 
using an Olympus Scan^R microscope. Previous to the EM acquisition, colloidal gold 
particles, 10 nm in diameter, were placed on top of the sections to serve as fiducial 
markers for alignment of the tomograms. Tilt series were acquired on a Tecnai F30 
microscope (FEI, Netherlands) operating at 300 kV with a OneView camera (Gatan Inc., 
USA) at a binned (2) pixel size of 1.25 nm using SerialEM (Mastronarde, 2005). Images 
were recorded at 1 degree intervals over a tilt range of +60 to -60 degrees. Electron and 
fluorescent images overlay were obtained by using ec-CLEM plugin (Paul-Gilloteaux et al., 
2017) from ICY software (de Chaumont et al., 2012) IMOD software package (Kremer et 
al., 1996) was used to create 3D reconstructions from the tilt series and to create 3D 
models of the autophagosomes and membranes. At least 3 different grids with 15-25 cells 
each and 2 or more region of interest per cell were acquired per condition. 
LIVE-CLEM assays: BV2 GFP-LC3 cells were grown on a gridded MatTek (Ashland, MA, 
USA) and live-imaged by widefield microscopy using a Zeiss Celldiscoverer7 microscope, 























the cell of interest was acquired at low magnification to visualize the grid and therefore 
precisely localize the position of the cell. Cells were fixed in 2.5% glutaraldehyde (GA, 
Electron Microscopy Sciences) in 0.1M cacodylate buffer immediately after detecting the 
event of interest. The subsequent EM processing steps (OSO4, UA, dehydration) were 
performed using a PELCO Biowave Pro microwave processor (Ted Pella, Inc.).  After 
dehydration the coverslip was detached from the MatTek dish and put on an Epon-filled 
capsule. After polymerization, the area containing the cell of interest was retrieved by 
means of the grid coordinate system that remained impressed on the block surface. The 
blocks were then sectioned with a Leica UC7 ultramicrotome and 300nm sections were 
collected on formvar coated slot grids. Tilt series of the cell of interest were acquired with a 
FEI Tecnai F30 electron microscope. Tomogram reconstruction, segmentation and 3D 
rendering was carried out with the IMOD software package (Kremer et al., 1996). 
 
Evaluation of mitochondrial quality, Cathepsin-B activity and lysoTracker staining  
BV2 microglial cells were left untreated or stimulated with fibrillar AS from 8 to 48h. After 
that, the cells were harvested, washed twice with fresh medium and incubated for 30min at 
37°C in DMEM supplemented with 10% heat-inactivated FCS containing the following 
dyes: 100 nM MitoSpy Green FM (Biolegend, 424805) to measure mitochondrial mass, 
100 nM MitoSpy Orange CMTMRos (Biolegend, 424803) to measure mitochondrial 
membrane potential and 26X Magic Red Cathepsin-B substrate (BioRad, ICT937) to 
measure Cathepsin-B activity. LysoTracker Red DND-99 staining (Invitrogen, L7528) was 
done following manufacturer instructions and the status of acidified organelles assessed 
by quantifying LysoTracker Red DND-99 fluorescence intensity by flow cytometry. In all 
cases, cells were washed and resuspended in 300uL of FACS buffer before acquisition. 
Flow cytometric analysis were performed on a FACSCanto II cytometer (Becton Dickinson) 

























Evaluation of cell death by flow cytometry 
BV2 microglial cells and primary microglial cells were washed twice with PBS and 
incubated with propidium iodide (PI) for 2 minutes in 300uL of FACS buffer. For annexin V 
(AnV) and PI dual staining, the cells were harvested, washed twice with binding buffer, and 
incubated with FITC-conjugated AnV and PI following manufacturer instructions (FITC 
Annexin V Apoptosis Detection Kit, Becton Dickinson). For Bcl-2, Bcl-xL and cleaved 
caspase-3 staining, BV2 cells were fixed and permeabilized by using Cytofix/Cytoperm kit 
(Becton Dickinson) and incubated with the monoclonal primary antibodies (Cell Signaling). 
After 1h, cells were washed and incubated for 30 min with an anti-rabbit Alexa Fluor 488 
antibody. After that cells were washed with PBS and resuspended in 300uL of FACS 
buffer. Microglial cells were then analysed by flow cytometry on a FACSCanto II cytometer 




The results were analysed using one-way analysis of variance (ANOVA) model, as 
indicated for every experiment. GraphPad Prism 6.0 was used to carry out the 
computations for all analyses. Results represent mean±SEM of at least three experiments. 
Statistical significance was defined as p≤0.05. 
 
Author Contributions 
C.B. performed all experiments, designed the research study and wrote the manuscript. 
J.M.P.R. and D.S.A. collaborated in cell culture, western blot, confocal microscopy and 
flow cytometry experiments. P.R and A.K collaborated in the design, acquisition and 
analysis of CLEM experiments, O.F. contributed with BV2 GFP-LC3 production and edited 
the manuscript, J.I.G. and M.S.C. contributed reagents/materials/analysis tools, Y.S. 
contributed with the design of CLEM experiments and edited the manuscript, N.T.K. 
contributed with reagents/materials/analysis tools, the design of the study and edited the 
manuscript, P.I. designed the research study and wrote the manuscript and is the 

























Acknowledgements: C.B. thanks to EMBO, EMBL, Boehringer Ingelheim Fonds, IUBMB 
Wood-Whelan Fellowship and to The Company of Biologists Travelling Fellowships for 
supporting short-research stays abroad. The authors would like to thank the Center of 
Micro and Nanoscopy of Cordoba (Cordoba, Argentina), the Imaging Facility at Babraham 
Institute (Cambridge, UK) and the Electron Microscopy Core Facility at EMBL (Heidelberg, 
Germany) for their technical assistance and helpful advice. We thank M. P. Abadie, M. P. 
Crespo, C. Mas, C. Sampedro, F. Navarro, D. Lutti, C. Florit, P. Icely and V. Blanco for 
their excellent technical assistance. 
 
Competing interest: The authors have no competing interest declared. 
 
Funding: This work was supported in part by Fondo para la Investigación Científica y 
Tecnológica (FONCyT) (PRESTAMO BID PICT 2014 2961) Argentina, Consejo Nacional 
de Investigaciones Científicas y Técnicas (CONICET) and Secretaria de Ciencia y 
Tecnología - Universidad Nacional de Córdoba (SECyT-UNC), Argentina. Its contents are 
solely the responsibility of the authors and do not necessarily represent the official views of 





























 Aits, S. and Jaattela, M. (2013). Lysosomal cell death at a glance. J Cell Sci 126, 1905-12. 
 Aits, S., Kricker, J., Liu, B., Ellegaard, A. M., Hamalisto, S., Tvingsholm, S., Corcelle-
Termeau, E., Hogh, S., Farkas, T., Holm Jonassen, A. et al. (2015). Sensitive detection of 
lysosomal membrane permeabilization by lysosomal galectin puncta assay. Autophagy 11, 1408-
24. 
 Arroyo, D. S., Soria, J. A., Gaviglio, E. A., Garcia-Keller, C., Cancela, L. M., Rodriguez-
Galan, M. C., Wang, J. M. and Iribarren, P. (2013). Toll-like receptor 2 ligands promote microglial 
cell death by inducing autophagy. FASEB J 27, 299-312. 
 Asai, H., Ikezu, S., Tsunoda, S., Medalla, M., Luebke, J., Haydar, T., Wolozin, B., 
Butovsky, O., Kugler, S. and Ikezu, T. (2015). Depletion of microglia and inhibition of exosome 
synthesis halt tau propagation. Nat Neurosci 18, 1584-93. 
 Axe, E. L., Walker, S. A., Manifava, M., Chandra, P., Roderick, H. L., Habermann, A., 
Griffiths, G. and Ktistakis, N. T. (2008). Autophagosome formation from membrane compartments 
enriched in phosphatidylinositol 3-phosphate and dynamically connected to the endoplasmic 
reticulum. J Cell Biol 182, 685-701. 
 Bir, A., Sen, O., Anand, S., Khemka, V. K., Banerjee, P., Cappai, R., Sahoo, A. and 
Chakrabarti, S. (2014). alpha-Synuclein-induced mitochondrial dysfunction in isolated preparation 
and intact cells: implications in the pathogenesis of Parkinson's disease. J Neurochem 131, 868-77. 
 Bisht, K., Sharma, K. P., Lecours, C., Sanchez, M. G., El Hajj, H., Milior, G., Olmos-
Alonso, A., Gomez-Nicola, D., Luheshi, G., Vallieres, L. et al. (2016). Dark microglia: A new 
phenotype predominantly associated with pathological states. Glia 64, 826-39. 
 Bourdenx, M., Bezard, E. and Dehay, B. (2014). Lysosomes and alpha-synuclein form a 
dangerous duet leading to neuronal cell death. Front Neuroanat 8, 83. 
 Bussi, C., Ramos, J. M., Arroyo, D. S., Gaviglio, E. A., Gallea, J. I., Wang, J. M., Celej, 
M. S. and Iribarren, P. (2017). Autophagy down regulates pro-inflammatory mediators in BV2 
microglial cells and rescues both LPS and alpha-synuclein induced neuronal cell death. Sci Rep 7, 
43153. 
 Celej, M. S., Sarroukh, R., Goormaghtigh, E., Fidelio, G. D., Ruysschaert, J.-M. and 
Raussens, V. (2012). Toxic prefibrillar α-synuclein amyloid oligomers adopt a distinctive antiparallel 
β-sheet structure. Biochemical journal 443, 719-726. 
 Chang, C., Lang, H., Geng, N., Wang, J., Li, N. and Wang, X. (2013). Exosomes of BV-2 
























 Cirman, T., Oresic, K., Mazovec, G. D., Turk, V., Reed, J. C., Myers, R. M., Salvesen, G. 
S. and Turk, B. (2004). Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated 
by cleavage of Bid by multiple papain-like lysosomal cathepsins. J Biol Chem 279, 3578-87. 
 Codolo, G., Plotegher, N., Pozzobon, T., Brucale, M., Tessari, I., Bubacco, L. and de 
Bernard, M. (2013). Triggering of inflammasome by aggregated alpha-synuclein, an inflammatory 
response in synucleinopathies. PLoS One 8, e55375. 
 de Chaumont, F., Dallongeville, S., Chenouard, N., Herve, N., Pop, S., Provoost, T., 
Meas-Yedid, V., Pankajakshan, P., Lecomte, T., Le Montagner, Y. et al. (2012). Icy: an open 
bioimage informatics platform for extended reproducible research. Nat Methods 9, 690-6. 
 Degenhardt, K., Mathew, R., Beaudoin, B., Bray, K., Anderson, D., Chen, G., 
Mukherjee, C., Shi, Y., Gelinas, C., Fan, Y. et al. (2006). Autophagy promotes tumor cell survival 
and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 10, 51-64. 
 Di Maio, R., Barrett, P. J., Hoffman, E. K., Barrett, C. W., Zharikov, A., Borah, A., Hu, 
X., McCoy, J., Chu, C. T., Burton, E. A. et al. (2016). alpha-Synuclein binds to TOM20 and inhibits 
mitochondrial protein import in Parkinson's disease. Sci Transl Med 8, 342ra78. 
 Droga-Mazovec, G., Bojic, L., Petelin, A., Ivanova, S., Romih, R., Repnik, U., Salvesen, 
G. S., Stoka, V., Turk, V. and Turk, B. (2008). Cysteine cathepsins trigger caspase-dependent cell 
death through cleavage of bid and antiapoptotic Bcl-2 homologues. J Biol Chem 283, 19140-50. 
 Dunn, W. A., Jr. (1990a). Studies on the mechanisms of autophagy: formation of the 
autophagic vacuole. J Cell Biol 110, 1923-33. 
 Dunn, W. A., Jr. (1990b). Studies on the mechanisms of autophagy: maturation of the 
autophagic vacuole. J Cell Biol 110, 1935-45. 
 Dupont, N., Nascimbeni, A. C., Morel, E. and Codogno, P. (2017). Molecular 
Mechanisms of Noncanonical Autophagy. Int Rev Cell Mol Biol 328, 1-23. 
 Esteves, A. R., Arduino, D. M., Silva, D. F., Oliveira, C. R. and Cardoso, S. M. (2011). 
Mitochondrial Dysfunction: The Road to Alpha-Synuclein Oligomerization in PD. Parkinsons Dis 
2011, 693761. 
 Flavin, W. P., Bousset, L., Green, Z. C., Chu, Y., Skarpathiotis, S., Chaney, M. J., 
Kordower, J. H., Melki, R. and Campbell, E. M. (2017). Endocytic vesicle rupture is a conserved 
mechanism of cellular invasion by amyloid proteins. Acta Neuropathol. 
 Florey, O., Kim, S. E., Sandoval, C. P., Haynes, C. M. and Overholtzer, M. (2011). 
Autophagy machinery mediates macroendocytic processing and entotic cell death by targeting 
single membranes. Nat Cell Biol 13, 1335-43. 
 Frake, R. A., Ricketts, T., Menzies, F. M. and Rubinsztein, D. C. (2015). Autophagy and 
neurodegeneration. J Clin Invest 125, 65-74. 
 Freeman, D., Cedillos, R., Choyke, S., Lukic, Z., McGuire, K., Marvin, S., Burrage, A. 
M., Sudholt, S., Rana, A., O'Connor, C. et al. (2013). Alpha-synuclein induces lysosomal rupture 























 Green, D. R. and Levine, B. (2014). To be or not to be? How selective autophagy and cell 
death govern cell fate. Cell 157, 65-75. 
 Hara, T., Nakamura, K., Matsui, M., Yamamoto, A., Nakahara, Y., Suzuki-Migishima, R., 
Yokoyama, M., Mishima, K., Saito, I., Okano, H. et al. (2006). Suppression of basal autophagy in 
neural cells causes neurodegenerative disease in mice. Nature 441, 885-9. 
 Hara, T., Takamura, A., Kishi, C., Iemura, S., Natsume, T., Guan, J. L. and Mizushima, 
N. (2008). FIP200, a ULK-interacting protein, is required for autophagosome formation in 
mammalian cells. J Cell Biol 181, 497-510. 
 Hayashi-Nishino, M., Fujita, N., Noda, T., Yamaguchi, A., Yoshimori, T. and 
Yamamoto, A. (2009). A subdomain of the endoplasmic reticulum forms a cradle for 
autophagosome formation. Nat Cell Biol 11, 1433-7. 
 Hoffmann, A., Ettle, B., Bruno, A., Kulinich, A., Hoffmann, A. C., von Wittgenstein, J., 
Winkler, J., Xiang, W. and Schlachetzki, J. C. (2016). Alpha-synuclein activates BV2 microglia 
dependent on its aggregation state. Biochem Biophys Res Commun 479, 881-886. 
 Jo, C., Gundemir, S., Pritchard, S., Jin, Y. N., Rahman, I. and Johnson, G. V. (2014). 
Nrf2 reduces levels of phosphorylated tau protein by inducing autophagy adaptor protein NDP52. 
Nat Commun 5, 3496. 
 Karanasios, E. and Ktistakis, N. T. (2015). Live-cell imaging for the assessment of the 
dynamics of autophagosome formation: focus on early steps. Methods 75, 54-60. 
 Karanasios, E., Walker, S. A., Okkenhaug, H., Manifava, M., Hummel, E., 
Zimmermann, H., Ahmed, Q., Domart, M. C., Collinson, L. and Ktistakis, N. T. (2016). 
Autophagy initiation by ULK complex assembly on ER tubulovesicular regions marked by ATG9 
vesicles. Nat Commun 7, 12420. 
 Kim, C., Ho, D. H., Suk, J. E., You, S., Michael, S., Kang, J., Joong Lee, S., Masliah, E., 
Hwang, D., Lee, H. J. et al. (2013). Neuron-released oligomeric alpha-synuclein is an endogenous 
agonist of TLR2 for paracrine activation of microglia. Nat Commun 4, 1562. 
 Komatsu, M., Waguri, S., Chiba, T., Murata, S., Iwata, J., Tanida, I., Ueno, T., Koike, M., 
Uchiyama, Y., Kominami, E. et al. (2006). Loss of autophagy in the central nervous system 
causes neurodegeneration in mice. Nature 441, 880-4. 
 Korac, J., Schaeffer, V., Kovacevic, I., Clement, A. M., Jungblut, B., Behl, C., Terzic, J. 
and Dikic, I. (2013). Ubiquitin-independent function of optineurin in autophagic clearance of protein 
aggregates. J Cell Sci 126, 580-92. 
 Kremer, J. R., Mastronarde, D. N. and McIntosh, J. R. (1996). Computer visualization of 
three-dimensional image data using IMOD. J Struct Biol 116, 71-6. 
 Ktistakis, N. T., Karanasios, E. and Manifava, M. (2014). Dynamics of autophagosome 
formation: a pulse and a sequence of waves. Biochem Soc Trans 42, 1389-95. 
 Ktistakis, N. T. and Tooze, S. A. (2016). Digesting the Expanding Mechanisms of 























 Kukulski, W., Schorb, M., Welsch, S., Picco, A., Kaksonen, M. and Briggs, J. A. (2012). 
Precise, correlated fluorescence microscopy and electron tomography of lowicryl sections using 
fluorescent fiducial markers. Methods Cell Biol 111, 235-57. 
 Lee, H. J., Bae, E. J. and Lee, S. J. (2014). Extracellular alpha--synuclein-a novel and 
crucial factor in Lewy body diseases. Nat Rev Neurol 10, 92-8. 
 Li, F., Xie, X., Wang, Y., Liu, J., Cheng, X., Guo, Y., Gong, Y., Hu, S. and Pan, L. (2016). 
Structural insights into the interaction and disease mechanism of neurodegenerative disease-
associated optineurin and TBK1 proteins. Nat Commun 7, 12708. 
 Liang, C. C., Wang, C., Peng, X., Gan, B. and Guan, J. L. (2010). Neural-specific deletion 
of FIP200 leads to cerebellar degeneration caused by increased neuronal death and axon 
degeneration. J Biol Chem 285, 3499-509. 
 Liu, J., Xia, H., Kim, M., Xu, L., Li, Y., Zhang, L., Cai, Y., Norberg, H. V., Zhang, T., 
Furuya, T. et al. (2011). Beclin1 controls the levels of p53 by regulating the deubiquitination activity 
of USP10 and USP13. Cell 147, 223-34. 
 Longhena, F., Faustini, G., Missale, C., Pizzi, M., Spano, P. and Bellucci, A. (2017). 
The Contribution of alpha-Synuclein Spreading to Parkinson's Disease Synaptopathy. Neural Plast 
2017, 5012129. 
 Loria, F., Vargas, J. Y., Bousset, L., Syan, S., Salles, A., Melki, R. and Zurzolo, C. 
(2017). alpha-Synuclein transfer between neurons and astrocytes indicates that astrocytes play a 
role in degradation rather than in spreading. Acta Neuropathol 134, 789-808. 
 Lumkwana, D., du Toit, A., Kinnear, C. and Loos, B. (2017). Autophagic flux control in 
neurodegeneration: Progress and precision targeting-Where do we stand? Prog Neurobiol. 
 Maejima, I., Takahashi, A., Omori, H., Kimura, T., Takabatake, Y., Saitoh, T., 
Yamamoto, A., Hamasaki, M., Noda, T., Isaka, Y. et al. (2013). Autophagy sequesters damaged 
lysosomes to control lysosomal biogenesis and kidney injury. EMBO J 32, 2336-47. 
 Maier, O., Marvin, S. A., Wodrich, H., Campbell, E. M. and Wiethoff, C. M. (2012). 
Spatiotemporal dynamics of adenovirus membrane rupture and endosomal escape. J Virol 86, 
10821-8. 
 Martin, L. J., Pan, Y., Price, A. C., Sterling, W., Copeland, N. G., Jenkins, N. A., Price, 
D. L. and Lee, M. K. (2006). Parkinson's disease alpha-synuclein transgenic mice develop 
neuronal mitochondrial degeneration and cell death. J Neurosci 26, 41-50. 
 Martinez, J., Almendinger, J., Oberst, A., Ness, R., Dillon, C. P., Fitzgerald, P., 
Hengartner, M. O. and Green, D. R. (2011). Microtubule-associated protein 1 light chain 3 alpha 
(LC3)-associated phagocytosis is required for the efficient clearance of dead cells. Proc Natl Acad 
Sci U S A 108, 17396-401. 
 Martinez, J., Malireddi, R. K., Lu, Q., Cunha, L. D., Pelletier, S., Gingras, S., Orchard, 























phagocytosis reveals distinct roles for Rubicon, NOX2 and autophagy proteins. Nat Cell Biol 17, 
893-906. 
 Mastronarde, D. N. (2005). Automated electron microscope tomography using robust 
prediction of specimen movements. J Struct Biol 152, 36-51. 
 Mazzulli, J. R., Zunke, F., Isacson, O., Studer, L. and Krainc, D. (2016). alpha-
Synuclein-induced lysosomal dysfunction occurs through disruptions in protein trafficking in human 
midbrain synucleinopathy models. Proc Natl Acad Sci U S A 113, 1931-6. 
 McGlinchey, R. P. and Lee, J. C. (2015). Cysteine cathepsins are essential in lysosomal 
degradation of alpha-synuclein. Proc Natl Acad Sci U S A 112, 9322-7. 
 Minowa-Nozawa, A., Nozawa, T., Okamoto-Furuta, K., Kohda, H. and Nakagawa, I. 
(2017). Rab35 GTPase recruits NDP52 to autophagy targets. EMBO J 36, 2790-2807. 
 Moore, A. S. and Holzbaur, E. L. (2016). Dynamic recruitment and activation of ALS-
associated TBK1 with its target optineurin are required for efficient mitophagy. Proc Natl Acad Sci U 
S A 113, E3349-58. 
 Nikoletopoulou, V., Papandreou, M. E. and Tavernarakis, N. (2015). Autophagy in the 
physiology and pathology of the central nervous system. Cell Death Differ 22, 398-407. 
 Nixon, R. A., Wegiel, J., Kumar, A., Yu, W. H., Peterhoff, C., Cataldo, A. and Cuervo, A. 
M. (2005). Extensive involvement of autophagy in Alzheimer disease: an immuno-electron 
microscopy study. J Neuropathol Exp Neurol 64, 113-22. 
 Osellame, L. D. and Duchen, M. R. (2014). Quality control gone wrong: mitochondria, 
lysosomal storage disorders and neurodegeneration. Br J Pharmacol 171, 1958-72. 
 Paul-Gilloteaux, P., Heiligenstein, X., Belle, M., Domart, M. C., Larijani, B., Collinson, 
L., Raposo, G. and Salamero, J. (2017). eC-CLEM: flexible multidimensional registration software 
for correlative microscopies. Nat Methods 14, 102-103. 
 Peelaerts, W., Bousset, L., Van der Perren, A., Moskalyuk, A., Pulizzi, R., Giugliano, 
M., Van den Haute, C., Melki, R. and Baekelandt, V. (2015). alpha-Synuclein strains cause 
distinct synucleinopathies after local and systemic administration. Nature 522, 340-4. 
 Ransohoff, R. M. (2016). How neuroinflammation contributes to neurodegeneration. 
Science 353, 777-83. 
 Reilly, S. M., Chiang, S. H., Decker, S. J., Chang, L., Uhm, M., Larsen, M. J., Rubin, J. 
R., Mowers, J., White, N. M., Hochberg, I. et al. (2013). An inhibitor of the protein kinases TBK1 
and IKK-varepsilon improves obesity-related metabolic dysfunctions in mice. Nat Med 19, 313-21. 
 Repnik, U., Hafner Cesen, M. and Turk, B. (2014). Lysosomal membrane 
permeabilization in cell death: concepts and challenges. Mitochondrion 19 Pt A, 49-57. 
 Sanchez-Guajardo, V., Tentillier, N. and Romero-Ramos, M. (2015). The relation 
between alpha-synuclein and microglia in Parkinson's disease: Recent developments. 























 Shamas-Din, A., Kale, J., Leber, B. and Andrews, D. W. (2013). Mechanisms of action of 
Bcl-2 family proteins. Cold Spring Harb Perspect Biol 5, a008714. 
 Sundblad, V., Croci, D. O. and Rabinovich, G. A. (2011). Regulated expression of 
galectin-3, a multifunctional glycan-binding protein, in haematopoietic and non-haematopoietic 
tissues. Histol Histopathol 26, 247-65. 
 Tait, S. W. and Green, D. R. (2010). Mitochondria and cell death: outer membrane 
permeabilization and beyond. Nat Rev Mol Cell Biol 11, 621-32. 
 Thurston, T. L., Wandel, M. P., von Muhlinen, N., Foeglein, A. and Randow, F. (2012). 
Galectin 8 targets damaged vesicles for autophagy to defend cells against bacterial invasion. 
Nature 482, 414-8. 
 Uchimoto, T., Nohara, H., Kamehara, R., Iwamura, M., Watanabe, N. and Kobayashi, Y. 
(1999). Mechanism of apoptosis induced by a lysosomotropic agent, L-Leucyl-L-Leucine methyl 
ester. Apoptosis 4, 357-62. 
 Wild, P., Farhan, H., McEwan, D. G., Wagner, S., Rogov, V. V., Brady, N. R., Richter, 
B., Korac, J., Waidmann, O., Choudhary, C. et al. (2011). Phosphorylation of the autophagy 
receptor optineurin restricts Salmonella growth. Science 333, 228-33. 
 Xilouri, M., Brekk, O. R. and Stefanis, L. (2016). Autophagy and Alpha-Synuclein: 
Relevance to Parkinson's Disease and Related Synucleopathies. Mov Disord 31, 178-92. 
 Xiong, S., Mu, T., Wang, G. and Jiang, X. (2014). Mitochondria-mediated apoptosis in 
mammals. Protein Cell 5, 737-49. 
 Yu, T., Yang, Y., Yin, D. Q., Hong, S., Son, Y. J., Kim, J. H. and Cho, J. Y. (2015). TBK1 





















































































Alpha-synuclein induces autophagy in microglial cells.  
(A) BV2 microglial cells were left untreated or stimulated at different time points with AS 
monomers (m) or fibrils (f) at 1uM. Cells were then fixed and stained for LC3. (B-H) BV2 
GFP-LC3 cells (B, C) or primary microglial cells (F, G) were left untreated or stimulated 
with Alexa Fluor 647-labeled AS fibrils (1M). After 12h cells were immunostained with 
anti-Lamp1 (red) antibody and primary microglial cells were also stained for LC3. Images 
shown are z-stack projections. (D) and (H) are 3D surface-rendered magnifications of the 
selected area above. (E, I) LC3 positive vesicles in unstimulated or treated BV2 (E) and 
primary microglial cells (I) were determined using ImageJ particle counting plugin after cell 
deconvolution (n=20). (J) Cell lysates from BV2 cells cultured with AS fibrils or monomers 
(1M) were collected at different time points and LC3B and -Actin protein levels were 
examined by Western immunoblotting. Bafilomycin A1 (BAF) was added for the last 3h. 
Graph shows quantification of LC3-II relative to -Actin by densitometry. Results from at 
least three independent experiments were analysed by one-way ANOVA followed by Post-


















































Figure 2.  
Evaluation of LC3 and ATG13 dynamics in AS-stimulated microglial cells by live-
imaging.  
(A, B). BV2 cells stably expressing GFP-LC3 (green) were stimulated with fAS (red) for 
12h. Imaging was performed at 1 frame per 10 s during 1h and a selected interval within 
this sequence is shown. LysoTracker Blue was added 30 min previous to imaging 
acquisition. Note that autophagosomes form a ring-like structure around LysoTracker+/ 
fAS+ structures. C, D. BV2 cells stably expressing GFP-ATG13 (green) were transfected 
with CFP-LC3 (red) and stimulated with fAS (blue) and imaged as described above. 
Arrowhead indicates the first discernible ATG13 punctum during autophagosome 


























Correlative Light-Electron Microscopy study of LC3 positive vesicles in fAS-
stimulated microglial cells.  
BV2 GFP-LC3 (green) cells were stimulated with fAS (red) for 12 h and incubated in the 
presence (G-J) or the absence (A-F) of BAF for the last 3h. Cells were then fixed by High 
Pressure Freezing (HPF) and processed for Optical and Electron Microscopy (EM) 
acquisition. 300 nm sections were imaged by fluorescence microscopy and EM 
tomograms were acquired at the regions of interest. (A) shows widefield and low (200X) 
and high-magnification (20000X) electron microscopy images with the overlay result. (B-J) 
show high-magnification slides (20000X) from representative tomograms of different cells 



















































Live-CLEM imaging of fAS-stimulated microglial cells. 
(A) BV2 GFP-LC3 cells (green) were stimulated with fAS (red) for 12h. Imaging was 
performed at 1 frame per 20 s. After detecting the event of interest (white box), cells were 
immediately fixed and processed for EM tomography. Twenty serial tomograms were 
acquired on 300nm sections. Scale bar, 5m. (B) and (D) show the overlay result 
indicating the area acquired at high magnification (9400X) in each tomogram. (E) 
representative slides of the serial tomogram are shown (scale bar, 500nm). Arrowhead 
indicates a central double membrane autophagosome. (C, G). Correlation result of a 
second live-CLEM experiment indicating the area acquired at high-magnification (9400X) 
in each serial tomogram. BV2 GFP-LC3 cells were stimulated and imaged as described 
above. Representative tomogram slides are shown in (H). Black arrowheads indicate a 
double-membrane autophagosome surrounded by ER membranes (white arrows). (F) and 




















































Evaluation of lysosomal damage in fAS-stimulated microglial cells. 
(A, B). BV2 cells were left untreated (A) or stimulated (B) with LLOME (500 M) for 2h. 
After that, cells were immunostained with anti-Gal3 (green) and anti-Lamp1 (red) 
antibodies. (C, D, E) BV2 (C) or primary microglial cells (D, E) were treated with fAS for 
12h. Cells were then fixed and stained for Gal-3 and Lamp-1 or LC3, as indicated. Merged 
images show orthogonal views and co-localization analysis between the specified labels. 
Pearson coefficient (R) and Overlap coefficient (R[r]) are listed. (F) BV2 microglial cells 
were stimulated with fibrillary (fAS) or monomeric (mAS) AS at the indicated time points. 
After that, cells were immunostained for GAL-3 and puncta formation were determined 
using ImageJ particle counting plugin (G) (scale bar, 5m). (H, I) BV2 cells were 
stimulated with fAS (5M) at different time points or left untreated. Microglial cells were 
then stained with MagicRed dye for evaluation of Cathepsin-B activity (H), MitoSpy Green 
FM for measuring mitochondrial mass or MitoSpy Orange CMTMRos for assessing 
mitochondrial membrane potential changes (I). Graphs show quantification of mean 
fluorescence intensity (Gmean) by flow cytometry.  Results were analysed by one-way 
ANOVA followed by Post-Hoc Dunnet´s test; n = 3. Error bars represent SEM (**, P < 0.01; 















































































TBK1 and OPTN are recruited after fAS stimulation in microglial cells 
(A) BV2 cells were stimulated with fibrillar (f) or monomeric (m) AS at different time points 
and cell lysates were collected for WB analysis. Arrowhead indicates shifted (phospho-) 
OPTN band. (B) shows band quantification of phospho (p) TBK1 relative to total TBK1 and 
OPTN relative to -actin levels. Results from at least three independent experiments were 
analysed by one-way ANOVA followed by Post-Hoc Dunnet´s test; n = 3. Error bars 
represent SEM (*, P < 0.05; **, P < 0.01) (C) primary microglial cells treated with fAS for 
12h were fixed and stained for ubiquitin (red), anti p-TBK1 or anti OPTN (green) and Gal-3 
(cyan). (D) BV2 GFP-LC3 cells (green) treated with fAS (cyan) for 12h were fixed and 
stained for p-TBK1 or OPTN (red). Image crops shows magnification of the selected areas 
(white box). (E) shows co-localization analysis of Fig. 6C and D between the specified 

















































Figure 7.  
Effects of TBK1 inhibition on LC3 and autophagy adaptors recruitment to damaged 
lysosomes after fAS stimulation. 
(A) BV2 cells were pre-treated with the TBK1 inhibitors BX795 (BX), Amlexanox (Am) and 
mrt67307 (mrt) for 1h or left untreated. After that, microglial cells were stimulated with fAS 
for 12h and cells lysates were examined by Western immunoblotting. The bar graph shows 
relative densitometry quantification of phospho (p) and total TBK1 bands. (B) BV2 cells 
pre-treated with Amlexanox or BX795 for 1h were stimulated with PP242 (PP2, 1M) and 
fAS (5 M) for 3h and 12h, respectively. Cell lysates were collected and analysed by 
Western immunoblotting. The bar graph shows relative densitometry quantification of LC3-
II and -actin bands. (C, D, E) BV2 GFP-LC3 cells treated with Amlexanox or left untreated 
were stimulated with fAS (5M, 12h) (C) or PP242 (1M, 3h) (D). fAS-stimulated microglial 
cells were also stained for GAL-3 for showing LC3/GAL-3 co-localization. (E) shows LC3 
puncta quantification for the indicated conditions using ImageJ particle counting plugin. (F, 
G) BV2 GFP-LC3 cells treated and stimulated as described in (C) were fixed and stained 
for p-TBK1 or OPTN (red) and GAL-3 (cyan). After that, p-TBK1 and OPTN puncta were 
quantified as shown in (H) and (I), respectively. Image crops shows magnification of the 
selected areas (white box). Results from at least three independent experiments were 
analysed by one-way ANOVA followed by Post-Hoc Dunnet´s test; n = 3. Error bars 
represent SEM (***, P < 0.001; ##, P < 0.01; ###, P < 0.001, fAS in comparison with fAS in 



















































Effects of fAS stimulation on Cathepsin-B activity, mitochondrial quality and 
microglial cell survival after autophagy inhibition. 
(A, B). BV2 microglial cells (A) or primary microglial cells (B) were left untreated or treated 
with spautin-1 (10 M) for 24h or FIP200 siRNA for 48h. Cells were then stimulated with 
fAS (5uM) for 24h and cell death was evaluated using propidium iodide (PI) combined with 
AnnexinV-FITC staining and subsequent flow cytometric analysis. Percentages of 
AnnexinV-FITC/IP double positive dead cells are shown. (C) BV2 microglial cells were 
treated and stimulated as described in (A) and Bcl-2, Bcl-xL and cleaved caspase-3 
protein levels were evaluated by flow cytometry. Graphs show representative histograms 
for each protein. (D, E) BV2 microglial cells were left untreated or treated with spautin-1 
(SP-1, 10 M) for 24h or siRNA FIP200 for 48h and stimulated with fAS (5uM) for 24h. 
Cathepsin-B activity (D) and mitochondrial mass and membrane potential (E) were 
measured as described in Fig. 5 H and I, respectively.  (F, G, H) shows Gal-3 
immunostaining (F), Gal-3 puncta quantification (G) and lysoTracker Red DND-99 staining 
(H) of BV2 cells treated with the autophagy inhibitors spautin-1 (SP-1, 10 M) for 24h or 
siRNA FIP200 for 48h (si, 48h) and stimulated with fAS (5uM) at the indicated time points. 
(H). LysoTracker staining was evaluated by flow cytometry and results are relative to the 
mean fluorescence intensity (Gmean) of the control condition. Results were analysed by 
one-way ANOVA followed by Post-Hoc Dunnet´s test; n = 3. Error bars represent SEM (*, 





























Additional evaluation of lysosomal markers and autophagy dynamics of fAS-
stimulated BV2 GFP-LC3 cells during early time points. 
(A) Primary microglial cells were stimulated with fAS for 12h and co-localization between 
lysosomal specific marker GALNS and fAS was analysed by confocal microscopy. Pearson 
coefficient (R) and Overlap coefficient (R[r]) are listed. Scale bar, 5m. 
(B, C, D). BV2 GFP-LC3 (green) cells were stimulated with fAS (1uM, red) for 1h. Imaging 
started immediately after cellular stimulation and it was performed at 1 frame per 10 s during 
1h, a selected interval within this sequence is shown. (C) shows fAS (red) and LysoTracker 
staining (green) of BV2 GFP-LC3 cells stimulated and imaged as described above. Of note 
that synuclein/LysoTracker co-localization is quickly observable after cellular internalization.  



















































Autophagy dynamics of fAS-stimulated BV2 GFP-LC3 cells during early time points 
(cont.) and comparison of single and double-membrane vesicles found in control and 
stimulated BV2 microglial cells. 
A, B. BV2 GFP-LC3 (green) cells were stimulated with fAS (red) for 6h and imaged at 1 
frame per 10 s during 1h, a selected interval within this sequence is shown. Scale bar, 2m. 
(C) Values are percentages of association of LC3-positive vesicles with fAS; ATG13-positive 
vesicles with LC3; and fAS with LysoTracker-positive vesicles corresponding to analysis of 
time-lapse experiments from the indicated figures. (D) Representative images from EM 
tomograms of control and fAS-stimulated BV2 GFP-LC3 microglial cells showing different 
single and double membrane AV (scale bar, 500nm). (E) Graphs show the AV size 
quantification in both conditions. Results were analysed by one-way ANOVA followed by 
Post-Hoc Dunnet´s test; n = 30. Error bars represent SEM (*, P < 0.05; **, P < 0.01). 



















































OPTN and pTBK1 are recruited to lysosomal damage sites in fAS-stimulated 
microglial cells.  
(A, B). BV2 cells were left untreated or stimulated with fibrillar (f) or monomeric (m) AS at the 
indicated time points. After that, cells were immunostained for pTBK1, ubiquitin (Ub) and 
OPTN. Puncta formation were determined using ImageJ particle counting plugin (B). Results 
were analysed by one-way ANOVA followed by Post-Hoc Dunnet´s test; n = 3. Error bars 
represent SEM (**, P < 0.01). (C) BV2 cells were stimulated with fAS (cyan) for 12h and 
were then fixed and stained for ubiquitin, pTBK1 and OPTN. Image crops shows 
magnification of the selected areas (white box). 


























NDP52 and p62 evaluation in fAS-stimulated microglial cells. (A)  BV2 microglial cells 
were stimulated with fAS (green) for 12h. After that, cells were fixed and stained for NDP52 
(red) and co-localization analysed with orthogonal views from z-stack confocal images. (B, 
C) fAS-stimulated BV2 GFP-LC3 cells were immunostained for NDP52 (red) and ubiquitin
(cyan). (C) shows co-localization analysis of the selected area (white square) indicated in 
(B). Pearson coefficient (R) and Overlap coefficient (R[r]) are listed. (D, E) BV2 cells were 
stimulated with fAS (5m) at the indicated time points or left untreated. Cells were then fixed 
and stained for p62 and p62-positive vesicles were quantified as shown in (E). (F) primary 
microglial cells were stimulated with fAS for 12h and stained for p62 (green). Co-localization 
was analysed with orthogonal views from z-stack confocal images after cellular 
deconvolution. A representative image sequence is shown (n=20). 


























Effects of spautin-1 and siRNAFIP200 on LC3 puncta induction. 
(B) Representative Immunofluorescence images of BV2 GFP-LC3 cells treated with the 
mTOR inhibitor PP242 (1uM) for 3h in the presence or the absence of spautin-1 (10 M) or 
siRNA FIP200. Spautin-1 and siRNA FIP200 were added 24h and 48 h before autophagy 
stimulation, respectively. (C) primary microglial cells were cultured in the presence or the 
absence of spautin-1 (10 M) or siRNA FIP200 and stimulated with fAS (red, 5uM). After 
12h, cells were immunostained for LC3 (green) and confocal images after cellular 
deconvolution are shown, scale bar, 5m. (D) shows LC3 puncta quantification of the 
conditions indicated in (B). (E) TEM of fAS (scale bar, 200nm). Results were analysed by 
one-way ANOVA followed by Post-Hoc Dunnet´s test; n = 3. Error bars represent SEM (**, P 
< 0.01; ***, P < 0.001). 

























(Movies 1-9) Video files showing autophagy dynamics at different time points after fAS 
stimulation of BV2 microglial cells. 
Movie 1
Movie 2

























Movies 1, 2, 3 and 4. BV2 GFP-LC3 cells (green) were stimulated with fAS (red) and imaged 
immediately (Movie 1 and 2) or 6h after stimulation (Movie 3 and 4). Of note that no 





























Movie 5. BV2 GFP-LC3 cells were stimulated with fAS (red) and imaged immediately 
after stimulation for 1h. LysoTracker (green) was used for lysosomal staining.
Movie 5



















































Movies 6 and 7. BV2 GFP-LC3 cells were stimulated with fAS for 12h and imaged at 1 
frame per 10 s during 1h. Movie 6 and 7 correspond to the sequence shown in Fig. 2A and 
Fig. 2B, respectively. Of note that LC3 (green) forms a ring-like structure around fAS (red). 
LysoTracker (blue) was used for lysosomal staining.  
Movie 7



























Movies 8 and 9. BV2 cells stably expressing ATG13 (green) were co-transfected with 
CFP-LC3 plasmid (red). Microglial cells were stimulated with fAS (blue) for 12h and imaged 
at 1 frame per 10 s during 1h. Movie 8 and 9 correspond to sequence shown in Fig. 2C 
and Fig. 2D, respectively. Of note that ATG13-positive structures mature into LC3-positive 
vesicles.  















































































Movies 10 – 13. EM tomograms from fAS-stimulated microglial cells.  
EM high-magnification (20000X) tomograms corresponding to the images indicated as Fig. 
3A (Movie 10), Fig. 3B (Movie 11), Fig. 3E (Movie 12) and Fig. 3G (Movie 13) are shown as 
video files. Of note, the presence of double membrane autophagosomes.  
Movie 14


























Movies 14, 15. Live imaging video file (Movie 14) and serial tomogram and 3D model (Movie 
15) corresponding to Fig 4A and Fig. 4E, respectively. Tomograms of twenty consecutive
300nm sections were acquired at 9400X magnification and later aligned. Movie 15 shows a 
central double-membrane autophagosome containing several vesicles.  


























 Movies 16 and 17. Live imaging video file (Movie 16) and serial tomogram and 3D 
model (Movie 17) corresponding to Fig. 4C and Fig. 4H, respectively. Movie 17 shows an 
inner autophagosome and multiple ER membranes surrounding it, suggesting it is an 
immature AV. Of note, an additional concentrical structure exhibiting a dense core is also 
exhibited.  
Movie 17
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